Pregabalin for neuropathic pain in adults
Background This review updates part of an earlier Cochrane Review titled" Pregabalin for
acute and chronic pain in adults", and considers only neuropathic pain (pain from damage to …
acute and chronic pain in adults", and considers only neuropathic pain (pain from damage to …
Abuse and misuse of pregabalin and gabapentin: a systematic review update
Background A 2017 systematic review (SR) identified 59 studies examining gabapentinoid
(pregabalin and gabapentin) misuse/abuse. Evidence of gabapentinoid misuse/abuse has …
(pregabalin and gabapentin) misuse/abuse. Evidence of gabapentinoid misuse/abuse has …
Gabapentin for chronic neuropathic pain in adults
Background Gabapentin is commonly used to treat neuropathic pain (pain due to nerve
damage). This review updates a review published in 2014, and previous reviews published …
damage). This review updates a review published in 2014, and previous reviews published …
How addictive are gabapentin and pregabalin? A systematic review
U Bonnet, N Scherbaum - European neuropsychopharmacology, 2017 - Elsevier
In the last ten years, gabapentin and pregabalin have been becoming dispensed broadly
and sold on black markets, thereby, exposing millions to potential side-effects. Meanwhile …
and sold on black markets, thereby, exposing millions to potential side-effects. Meanwhile …
Drug delivery challenges in brain disorders across the blood–brain barrier: novel methods and future considerations for improved therapy
A Achar, R Myers, C Ghosh - Biomedicines, 2021 - mdpi.com
Due to the physiological and structural properties of the blood–brain barrier (BBB), the
delivery of drugs to the brain poses a unique challenge in patients with central nervous …
delivery of drugs to the brain poses a unique challenge in patients with central nervous …
Opioid tolerance in critical illness
JAJ Martyn, J Mao, EA Bittner - New England Journal of Medicine, 2019 - Mass Medical Soc
Opioid Tolerance in Critical Illness | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Pharmacologic treatment for temporomandibular and temporomandibular joint disorders
A Andre, J Kang, H Dym - Oral and …, 2022 - oralmaxsurgery.theclinics.com
Temporomandibular joint (TMJ) disorders refers to multietiological conditions defined by
pain and/or loss of function of the TMJ, the muscles of mastication, and other associated …
pain and/or loss of function of the TMJ, the muscles of mastication, and other associated …
Some prospective alternatives for treating pain: the endocannabinoid system and its putative receptors GPR18 and GPR55
R Guerrero-Alba, P Barragán-Iglesias… - Frontiers in …, 2019 - frontiersin.org
Background: Marijuana extracts (cannabinoids) have been used for several millennia for
pain treatment. Regarding the site of action, cannabinoids are highly promiscuous …
pain treatment. Regarding the site of action, cannabinoids are highly promiscuous …
Pharmacokinetic drug–drug interactions among antiepileptic drugs, including CBD, drugs used to treat COVID-19 and nutrients
M Karaźniewicz-Łada, AK Główka, AA Mikulska… - International Journal of …, 2021 - mdpi.com
Anti-epileptic drugs (AEDs) are an important group of drugs of several generations, ranging
from the oldest phenobarbital (1912) to the most recent cenobamate (2019). Cannabidiol …
from the oldest phenobarbital (1912) to the most recent cenobamate (2019). Cannabidiol …
[HTML][HTML] Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market
SED Clarke, AH Kral, JE Zibbell - International Journal of Drug Policy, 2022 - Elsevier
Abstract Background North America continues to face an opioid overdose epidemic, driven
by persistent increases in illicit fentanyls and fluctuations in potency leading to uncertainty …
by persistent increases in illicit fentanyls and fluctuations in potency leading to uncertainty …